233 related articles for article (PubMed ID: 20105122)
1. Lycorine and its derivatives for anticancer drug design.
Lamoral-Theys D; Decaestecker C; Mathieu V; Dubois J; Kornienko A; Kiss R; Evidente A; Pottier L
Mini Rev Med Chem; 2010 Jan; 10(1):41-50. PubMed ID: 20105122
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxic agents of the crinane series of amaryllidaceae alkaloids.
Nair JJ; Bastida J; Viladomat F; van Staden J
Nat Prod Commun; 2012 Dec; 7(12):1677-88. PubMed ID: 23413581
[TBL] [Abstract][Full Text] [Related]
3. Lycorine: A prospective natural lead for anticancer drug discovery.
Roy M; Liang L; Xiao X; Feng P; Ye M; Liu J
Biomed Pharmacother; 2018 Nov; 107():615-624. PubMed ID: 30114645
[TBL] [Abstract][Full Text] [Related]
4. Acetylcholinesterase inhibition within the lycorine series of Amaryllidaceae alkaloids.
Nair JJ; van Staden J
Nat Prod Commun; 2012 Jul; 7(7):959-62. PubMed ID: 22908593
[TBL] [Abstract][Full Text] [Related]
5. Structure-activity studies on the lycorine pharmacophore: A potent inducer of apoptosis in human leukemia cells.
McNulty J; Nair JJ; Bastida J; Pandey S; Griffin C
Phytochemistry; 2009 May; 70(7):913-9. PubMed ID: 19464034
[TBL] [Abstract][Full Text] [Related]
6. C1,C2-ether derivatives of the Amaryllidaceae alkaloid lycorine: retention of activity of highly lipophilic analogues against cancer cells.
Dasari R; Banuls LM; Masi M; Pelly SC; Mathieu V; Green IR; van Otterlo WA; Evidente A; Kiss R; Kornienko A
Bioorg Med Chem Lett; 2014 Feb; 24(3):923-7. PubMed ID: 24393582
[TBL] [Abstract][Full Text] [Related]
7. Amaryllidaceae alkaloids belonging to different structural subgroups display activity against apoptosis-resistant cancer cells.
Van Goietsenoven G; Andolfi A; Lallemand B; Cimmino A; Lamoral-Theys D; Gras T; Abou-Donia A; Dubois J; Lefranc F; Mathieu V; Kornienko A; Kiss R; Evidente A
J Nat Prod; 2010 Jul; 73(7):1223-7. PubMed ID: 20550100
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of Amaryllidaceae Constituents and Unnatural Derivatives.
Ghavre M; Froese J; Pour M; Hudlicky T
Angew Chem Int Ed Engl; 2016 May; 55(19):5642-91. PubMed ID: 26969844
[TBL] [Abstract][Full Text] [Related]
9. Lycorine derivatives against Trichomonas vaginalis.
Giordani RB; Junior CO; de Andrade JP; Bastida J; Zuanazzi JA; Tasca T; de Almeida MV
Chem Biol Drug Des; 2012 Jul; 80(1):129-33. PubMed ID: 22260620
[TBL] [Abstract][Full Text] [Related]
10. Chemical and Biological Aspects of Montanine-Type Alkaloids Isolated from Plants of the Amaryllidaceae Family.
Koutová D; Maafi N; Havelek R; Opletal L; Blunden G; Řezáčová M; Cahlíková L
Molecules; 2020 May; 25(10):. PubMed ID: 32429491
[TBL] [Abstract][Full Text] [Related]
11. Narciclasine - an Amaryllidaceae Alkaloid with Potent Antitumor and Anti-Inflammatory Properties.
Fürst R
Planta Med; 2016 Nov; 82(16):1389-1394. PubMed ID: 27542176
[TBL] [Abstract][Full Text] [Related]
12. In search of a cytostatic agent derived from the alkaloid lycorine: synthesis and growth inhibitory properties of lycorine derivatives.
Evdokimov NM; Lamoral-Theys D; Mathieu V; Andolfi A; Frolova LV; Pelly SC; van Otterlo WA; Magedov IV; Kiss R; Evidente A; Kornienko A
Bioorg Med Chem; 2011 Dec; 19(23):7252-61. PubMed ID: 22019045
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxicity studies of lycorine alkaloids of the Amaryllidaceae.
Nair JJ; van Staden J
Nat Prod Commun; 2014 Aug; 9(8):1193-210. PubMed ID: 25233606
[TBL] [Abstract][Full Text] [Related]
14. Selective cytochrome P450 3A4 inhibitory activity of Amaryllidaceae alkaloids.
McNulty J; Nair JJ; Singh M; Crankshaw DJ; Holloway AC; Bastida J
Bioorg Med Chem Lett; 2009 Jun; 19(12):3233-7. PubMed ID: 19428250
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and antiplasmodial activity of lycorine derivatives.
Cedrón JC; Gutiérrez D; Flores N; Ravelo AG; Estévez-Braun A
Bioorg Med Chem; 2010 Jul; 18(13):4694-701. PubMed ID: 20627737
[TBL] [Abstract][Full Text] [Related]
16. Design, Synthesis and Structure-Activity Relationship Optimization of Lycorine Derivatives for HCV Inhibition.
Chen D; Cai J; Cheng J; Jing C; Yin J; Jiang J; Peng Z; Hao X
Sci Rep; 2015 Oct; 5():14972. PubMed ID: 26443922
[TBL] [Abstract][Full Text] [Related]
17. Antibacterial activity and virtual screening by molecular docking of lycorine from Pancratium foetidum Pom (Moroccan endemic Amaryllidaceae).
Bendaif H; Melhaoui A; Ramdani M; Elmsellem H; Douez C; El Ouadi Y
Microb Pathog; 2018 Feb; 115():138-145. PubMed ID: 29253598
[TBL] [Abstract][Full Text] [Related]
18. Anti-dengue-virus activity and structure-activity relationship studies of lycorine derivatives.
Wang P; Li LF; Wang QY; Shang LQ; Shi PY; Yin Z
ChemMedChem; 2014 Jul; 9(7):1522-33. PubMed ID: 24574246
[TBL] [Abstract][Full Text] [Related]
19. Antitumoral activity of different Amaryllidaceae alkaloids: In vitro and in silico assays.
Tallini LR; Machado das Neves G; Vendruscolo MH; Rezende-Teixeira P; Borges W; Bastida J; Costa-Lotufo LV; Eifler-Lima VL; Zuanazzi JAS
J Ethnopharmacol; 2024 Jul; 329():118154. PubMed ID: 38614259
[TBL] [Abstract][Full Text] [Related]
20. Lycorine, the main phenanthridine Amaryllidaceae alkaloid, exhibits significant antitumor activity in cancer cells that display resistance to proapoptotic stimuli: an investigation of structure-activity relationship and mechanistic insight.
Lamoral-Theys D; Andolfi A; Van Goietsenoven G; Cimmino A; Le Calvé B; Wauthoz N; Mégalizzi V; Gras T; Bruyère C; Dubois J; Mathieu V; Kornienko A; Kiss R; Evidente A
J Med Chem; 2009 Oct; 52(20):6244-56. PubMed ID: 19788245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
